MACROCURE

macrocure-logo

MacroCure is a biotechnology company focused on the development and commercialization of advanced cell therapy products. The company's first focus of interest is in the arena of wound care. The technology employs activated white blood cells obtained from young adults healthy donor blood. The activated cells provide the natural environment for wound healing, and ensure that necessary cell activities and factor secretions are maintained as required for wound healing. This novel concept is the first of its kind in the field of wound therapy.

#SimilarOrganizations #People #Financial #Website #More

MACROCURE

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2008-01-01

Address:
Petah Tiqva, HaMerkaz, Israel

Country:
Israel

Website Url:
http://www.macrocure.com

Total Employee:
11+

Status:
Closed

Contact:
+972 3-923-5556

Total Funding:
48 M USD

Technology used in webpage:
SPF Amazon Amazon Frankfurt Region Omniture SiteCatalyst Edgar Online


Similar Organizations

immutep-logo

Immutep

Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.


Current Advisors List

ranan-grobman_image

Ranan Grobman Board Member @ MacroCure
Board_member

Current Employees Featured

not_available_image

Mitchell Shirvan
Mitchell Shirvan President & Co-Chief Executive Officer @ MacroCure
President & Co-Chief Executive Officer
2008-01-01

nissim-mashiach_image

Nissim Mashiach
Nissim Mashiach President & Chief Executive Officer @ MacroCure
President & Chief Executive Officer
2012-06-01

Stock Details


Company's stock symbol is NASDAQ:MCUR

Investors List

jerusalem-global-ventures_image

Jerusalem Global Ventures

Jerusalem Global Ventures investment in Series A - MacroCure

rainfall-ventures_image

Rainfall Ventures

Rainfall Ventures investment in Series A - MacroCure

violagrowth_image

Viola Growth

Viola Growth investment in Venture Round - MacroCure

docor-international-management_image

Docor International Management

Docor International Management investment in Venture Round - MacroCure

pontifax_image

Pontifax

Pontifax investment in Venture Round - MacroCure

Official Site Inspections

http://www.macrocure.com

  • Host name: a904c694c05102f30.awsglobalaccelerator.com
  • IP address: 76.223.54.146
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "MacroCure"

MacroCure - Crunchbase Company Profile & Funding

MacroCure is a biotechnology company focused on the development and commercialization of advanced cell therapy products. The company's first focus of interest is in the arena of wound …See details»

Leap Acquires Macrocure - Technology Networks

Sep 5, 2016 · Leap Therapeutics, Inc. and Macrocure Ltd. have announced the signing of a definitive merger agreement. Under the terms of the agreement, Macrocure will become a …See details»

Macrocure - LinkedIn

MacroCure is a biotechnology company focused on the development and commercialization of advanced cell therapy products. The company's first focus of interest is in the arena of wound …See details»

MacroCure Company Profile 2024: Valuation, Investors …

MacroCure is headquartered in Radnor, PA. What is the size of MacroCure? MacroCure has 11 total employees. What industry is MacroCure in? MacroCure’s primary industry is Biotechnology. Is MacroCure a private or public company? …See details»

Leap Therapeutics and Macrocure Announce Definitive Merger …

Aug 29, 2016 · Leap Therapeutics, Inc., a clinical stage immuno-oncology company, and Macrocure Ltd. (NASDAQ: MCUR) today announced the signing of a definitive merger …See details»

MacroCure - Products, Competitors, Financials, Employees, …

Macrocure is a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic and hard-to-heal wounds, such as diabetic foot ulcers …See details»

MacroCure - Funding, Financials, Valuation & Investors - Crunchbase

MacroCure is a biopharmaceutical company focusing on solutions to chronic wounds.See details»

Macrocure and Leap Therapeutics Complete Merger - PR Newswire

Jan 23, 2017 · Macrocure Ltd. (NASDAQ: MCUR), a clinical-stage biotechnology company, announced today that the previously reported merger transaction with a wholly-owned …See details»

MacroCure - Crunchbase

MacroCure is a biopharmaceutical company focusing on solutions to chronic wounds.See details»

MacroCure - Foreign Startup | Startup Nation Finder

MacroCure Ltd is a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic and hard-to-heal wounds, such as diabetic foot ulcers …See details»

Leap reverse merges, secures $30M for I/O antibodies

Aug 29, 2016 · Immuno-oncology antibody company Leap Therapeutics has reverse merged with Israeli public wound care player Macrocure ($MCUR). This is at least the third recent biotech …See details»

Advanced cell therapy for chronic wounds - ISRAEL21c

Aug 2, 2011 · Petah Tikvah-based MacroCure has a product that aims to do what the body can’t: Heal wounds that have festered for months, if not years. CureXcell is unique in a number of …See details»

Leap Therapeutics to Acquire Macrocure - genengnews.com

Aug 29, 2016 · Leap Therapeutics will acquire Macrocure in a deal intended to create a stronger developer of immune-oncology treatments. The combined company, Leap and Macrocure …See details»

MacroCure - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Oct 27, 2024 · MacroCure is a biopharmaceutical company focusing on solutions to chronic wounds.See details»

Israeli biotech Macrocure sets terms for $75 million IPO

Jul 28, 2014 · Macrocure, a late-stage Israeli biotech developing white blood cell injections to treat hard-to-heal and chronic wounds, has announced terms for its $75 million IPO. The Petach …See details»

Macrocure (MCUR) Completes Merger with Leap Therapeutics

Jan 23, 2017 · Macrocure Ltd. (NASDAQ: MCUR) announced today that the previously reported merger transaction with a wholly-owned subsidiary of Leap Therapeutics, Inc. has been …See details»

Israeli Biotech Macrocure Sets Terms for $75 million IPO

Jul 30, 2014 · Macrocure, a late-stage Israeli biotech developing white blood cell injections to treat hard-to-heal and chronic wounds, has announced terms for its $75 million IPO. The Petach …See details»

MacroCure - Contacts, Employees, Board Members, Advisors

MacroCure is a biopharmaceutical company focusing on solutions to chronic wounds.See details»

Leap Therapeutics Enters Agreement to Acquire Macrocure (MCUR)

Aug 29, 2016 · Leap Therapeutics, Inc. and Macrocure Ltd. (Nasdaq: MCUR) announced the signing of a definitive merger agreement. Under the terms of the agreement, Macrocure will …See details»

Macrocure Ltd. - Ordinary Share (MCUR) - Yahoo Finance Canada

Find the latest Macrocure Ltd. - Ordinary Share (MCUR) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»

linkstock.net © 2022. All rights reserved